These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 54967

  • 21. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP, Storb R, Weiden PL, Mickelson EM, Thomas ED.
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction.
    Sadeghee S, Hebert J, Kelley J, Abdou NI.
    J Immunol; 1975 Sep; 115(3):811-6. PubMed ID: 125303
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The human major histocompatibility system.
    Thorsby E.
    Transplant Rev; 1974 Sep; 18():51-129. PubMed ID: 4141523
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Humoral factors. Immunologic enhancement.
    Batchelor JR, Welsh KI, Burgos H.
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract] [Full Text] [Related]

  • 30. Functional characterization of blocking antibody after human renal transplantation.
    Miller J, Lifton J, Rood F, Kyriakides G, Gajl-Peczalska KY, Yunis EJ, Hattler BG.
    Surgery; 1974 Jul; 76(1):129-41. PubMed ID: 4135311
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Donor-specific decreased cell-mediated cytotoxicity in recipients of well functioning, one HLA haplotype-mismatched kidney allografts.
    Pfeffer PF, Thorsby E, Hirschberg H.
    Transplantation; 1983 Feb; 35(2):156-60. PubMed ID: 6187111
    [Abstract] [Full Text] [Related]

  • 34. Circulating antibodies in allograft recipients.
    Revillard JP, Betuel H.
    Adv Nephrol Necker Hosp; 1975 Feb; 5():257-81. PubMed ID: 127522
    [No Abstract] [Full Text] [Related]

  • 35. The association between the HLA system and disease.
    McMichael A, McDevitt H.
    Prog Med Genet; 1977 Feb; 2():39-100. PubMed ID: 142998
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The human mixed lymphocyte culture (MLC) interaction after in vivo alloimmunization. I. Kinetics.
    Bondevik H, Thorsby E.
    Cell Immunol; 1974 Mar 30; 11(1-3):409-18. PubMed ID: 4281726
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.